The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
Open accessAbstract
The existence of local or tissue-based renin-angiotensin-aldosterone systems (RAAS) is well documented and has been implicated as a key player in the pathogenesis of cardiovascular and renal diseases. The kidney contains all elements of the RAAS, and intrarenal formation of angiotensin II not only controls glomerular hemodynamics and tubule sodium transport, but also activates a number of inflammatory and fibrotic pathways. Experimental and clinical studies have shown that the intrarenal RAAS is activated early in diabetic nephropathy, the leading cause of chronic kidney disease (CKD). Although angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the rate of decline in kidney function in patients with diabetic and non-diabetic nephropathy, many patients still progress to end-stage renal disease or die from cardiovascular events. There is still a clear need for additional strategies to block the RAAS more effectively to reduce progression of CKD. The focus of this paper is to review the importance of the intrarenal RAAS in CKD and recent findings in renin-angiotensin biology pertinent to the kidney. We also discuss additional strategies to inhibit the RAAS more effectively and the potential impact of direct renin inhibition on the prevention and management of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909 · cited 1×
“The intrarenal RAAS is activated early in diabetes yet the exact mechanism is unknown. The discovery of GPR91, a G-protein-coupled receptor that is activated by succinate [”
BackgroundThe Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
Atlas, S. A. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.s8-b.9 · Cited by 722
Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 717
Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I., & Batlle, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050423 · Cited by 485
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Rüster, C., & Wolf, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040356 · Cited by 463
Role of the Angiotensin Type 2 Receptor in the Regulation of Blood Pressure and Renal Function
Carey, R. M., Wang, Z.-Q., & Siragy, H. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.155 · Cited by 431
Self-citationHuang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
Toma, I., Kang, J. J., Sipos, A., Vargas, S., Bansal, E., Hanner, F., Meer, E., & Peti-Peterdi, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33293 · Cited by 322
Parving, H.-H., Brenner, B. M., McMurray, J. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn721 · Cited by 304
Schefe, J. H., Menk, M., Reinemund, J., Effertz, K., Hobbs, R. M., Pandolfi, P. P., Ruiz, P., Unger, T., & Funke-Kaiser, H. (2006) · Circulation Research · doi:10.1161/01.res.0000251700.00994.0d · Cited by 302
Feldman, D. L., Jin, L., Xuan, H., Contrepas, A., Zhou, Y., Webb, R. L., Mueller, D. N., Feldt, S., Cumin, F., Maniara, W., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108845 · Cited by 283
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
Bomback, A. S., Kshirsagar, A. V., Amamoo, M. A., & Klemmer, P. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.040 · Cited by 261
Kaneshiro, Y., Ichihara, A., Sakoda, M., Takemitsu, T., Nabi, A. H. M. N., Uddin, M. N., Nakagawa, T., Nishiyama, A., Suzuki, F., Inagami, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091062 · Cited by 256
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 251
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
Pilz, B., Shagdarsuren, E., Wellner, M., Fiebeler, A., Dechend, R., Gratze, P., Meiners, S., Feldman, D. L., Webb, R. L., Garrelds, I. M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000179573.91016.3f · Cited by 245
Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241
Huang, X. R., Chen, W. Y., Truong, L. D., & Lan, H. Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000071512.93927.4e · Cited by 228
Elevated Blood Pressure and Heart Rate in Human Renin Receptor Transgenic Rats
Burcklé, C. A., Jan Danser, A. H., Müller, D. N., Garrelds, I. M., Gasc, J.-M., Popova, E., Plehm, R., Peters, J., Bader, M., & Nguyen, G. (2006) · Hypertension · doi:10.1161/01.hyp.0000199912.47657.04 · Cited by 221
Kobori, H., Alper, A. B., Shenava, R., Katsurada, A., Saito, T., Ohashi, N., Urushihara, M., Miyata, K., Satou, R., Hamm, L. L., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123802 · Cited by 208
Yamamoto, T., Nakagawa, T., Suzuki, H., Ohashi, N., Fukasawa, H., Fujigaki, Y., Kato, A., Nakamura, Y., Suzuki, F., & Hishida, A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060554 · Cited by 194
The Collecting Duct Is the Major Source of Prorenin in Diabetes
Kang, J. J., Toma, I., Sipos, A., Meer, E. J., Vargas, S. L., & Peti-Peterdi, J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107268 · Cited by 173
Kelly, D. J., Zhang, Y., Moe, G., Naik, G., & Gilbert, R. E. (2007) · Diabetologia · doi:10.1007/s00125-007-0795-9 · Cited by 167
Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans
Fisher, N. D. L., Jan Danser, A. H., Nussberger, J., Dole, W. P., & Hollenberg, N. K. (2008) · Circulation · doi:10.1161/circulationaha.108.767202 · Cited by 163
Persson, F., Rossing, P. R., Reinhard, H., Juhl, T. R., Stehouwer, C. D. A., Schalkwijk, C. G., Danser, A. H. J., Boomsma, F., Frandsen, E. L., & Parving, H. (2009) · Diabetes Care · doi:10.2337/dc09-0168 · Cited by 151
Persson, F., Rossing, P. R., Schjoedt, K. J., Juhl, T. R., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C., Boomsma, F., Frandsen, E., & Parving, H.-H. (2008) · Kidney International · doi:10.1038/ki.2008.68 · Cited by 143
Complement Activation in Angiotensin II–Induced Organ Damage
Shagdarsuren, E., Wellner, M., Bräsen, J. H., Park, J.-K., Fiebeler, A., Henke, N., Dechend, R., Gratze, P., Luft, F. C., & Müller, D. N. (2005) · Circulation Research · doi:10.1161/01.res.0000182677.89816.38 · Cited by 128
Xue, C., & Siragy, H. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000175814.18550.c0 · Cited by 124
Self-citationGlomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus
Hollenberg, N. K., Price, D. A., Fisher, N. D. L., Lansang, M. C., Perkins, B. A., Gordon, M. S., Williams, G. H., & Laffel, L. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00701.x · Cited by 119
Saito, T., Kobori, H., Urushihara, M., et al. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181b90c25 · Cited by 117
Role of the 11β-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
Ferrari, P., & Krozowski, Z. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00978.x · Cited by 106
Peters, B. S., Grisk, O., Becher, B., Wanka, H., Kuttler, B., Lüdemann, J., Lorenz, G., Rettig, R., Mullins, J., & Peters, J. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f0ab66 · Cited by 102
Young Scholars Award Lecture: Intratubular Angiotensinogen in Hypertension and Kidney Diseases
Kobori, H., Ozawa, Y., Suzaki, Y., Prieto‐Carrasquero, M. C., Nishiyama, A., SHOJI, T., COHEN, E., & NAVAR, L. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.11.014 · Cited by 101
Function of connexins in the renal circulation
Wagner, C. (2007) · Kidney International · doi:10.1038/sj.ki.5002720 · Cited by 82
Chronic Increases in Circulating Prorenin Are not Associated With Renal or Cardiac Pathologies
Mercure, C., Prescott, G., Lacombe, M., Silversides, D. W., & Reudelhuber, T. L. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.115444 · Cited by 81
Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon
Kyossev, Z. N., Walker, P. D., & Reeves, W. B. (1996) · Kidney International · doi:10.1038/ki.1996.39 · Cited by 75
Lee, S. H., Yoo, T., Nam, B.-Y., Kim, D. K., Li, J. J., Jung, D.-S., Kwak, S.-J., Ryu, D., Han, S. H., Lee, J. E., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2009 · Cited by 73
Sakoda, M., Ichihara, A., Kurauchi‐Mito, A., Narita, T., Kinouchi, K., Murohashi-Bokuda, K., Saleem, M. A., Nishiyama, A., Suzuki, F., & Itoh, H. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.273 · Cited by 64
Hanner, F., von Maltzahn, J., Maxeiner, S., Toma, I., Sipos, A., Krüger, O., Willecke, K., & Peti‐Peterdi, J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00468.2007 · Cited by 61
Renin-angiotensin blockade and kidney disease
Sarafidis, P. A., & Bakris, G. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61212-x · Cited by 56
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Oparil, S. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4291 · Cited by 44
Angiotensin II regulates 11β-hydroxysteroid dehydrogenase type 2 via AT2 receptors
Lanz, B., Kadereit, B., Ernst, S., Shojaati, K., Causevic, M., Frey, B. M., Frey, F. J., & Mohaupt, M. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00192.x · Cited by 43
Danser, A. J. (2009) · Hypertension Research · doi:10.1038/hr.2009.186 · Cited by 41
Feldman, D. L. (2010) · Hypertension Research · doi:10.1038/hr.2010.19 · Cited by 37
Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases
Yarows, S. A. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.143 · Cited by 17
Angiotensin administration stimulates renal 11β-hydroxysteroid dehydrogenase activity in healthy men
Kerstens, M. N., van der Kleij, F. G. H., Boonstra, A. H., Sluiter, W. J., van der Molen, J. C., Navis, G. J., & Dullaart, R. P. F. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00626.x · Cited by 6
Cited by
Combined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Alonso, A., Lopez, F. L., Matsushita, K., Loehr, L. R., Agarwal, S. K., Chen, L. Y., Soliman, E. Z., Astor, B. C., & Coresh, J. (2011) · Circulation · doi:10.1161/circulationaha.111.020982 · Cited by 529
Endothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
NAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
Michel, M. C., Foster, C., Brunner, H. R., & Liu, L. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007278 · Cited by 301
Metadata
- Authors
- Siragy, H. M., & Carey, R. M.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 31
- Issue
- 6
- Pages
- 541-550
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2108616699
- Cited by
- 293
- References
- 59
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.